Salima Kalla

430 total citations
5 papers, 366 citations indexed

About

Salima Kalla is a scholar working on Oncology, Dermatology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Salima Kalla has authored 5 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 2 papers in Dermatology and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Salima Kalla's work include Cancer Treatment and Pharmacology (4 papers), Chemotherapy-induced cardiotoxicity and mitigation (2 papers) and Neutropenia and Cancer Infections (2 papers). Salima Kalla is often cited by papers focused on Cancer Treatment and Pharmacology (4 papers), Chemotherapy-induced cardiotoxicity and mitigation (2 papers) and Neutropenia and Cancer Infections (2 papers). Salima Kalla collaborates with scholars based in France. Salima Kalla's co-authors include P Pouillart, Véronique Dièras, C. Cuvier, Esteban Cvitkovic, J. L. Misset, N. Azli, D. Méry-Mignard, M. Spielmann, Jean-­Marc Ferrero and Marc Espié and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

Salima Kalla

5 papers receiving 357 citations

Peers

Salima Kalla
P. Marpicati Italy
Hideaki Aoyama Japan
R. K. Ramanathan United States
Mario Brandi Italy
S. Sugarman United States
Monica Capozzi Italy
Sachi Morita Japan
Nebojša Manojlović Serbia
Giovanna Antonelli Italy
Johan M. van Rooijen Netherlands
P. Marpicati Italy
Salima Kalla
Citations per year, relative to Salima Kalla Salima Kalla (= 1×) peers P. Marpicati

Countries citing papers authored by Salima Kalla

Since Specialization
Citations

This map shows the geographic impact of Salima Kalla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salima Kalla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salima Kalla more than expected).

Fields of papers citing papers by Salima Kalla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Salima Kalla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salima Kalla. The network helps show where Salima Kalla may publish in the future.

Co-authorship network of co-authors of Salima Kalla

This figure shows the co-authorship network connecting the top 25 collaborators of Salima Kalla. A scholar is included among the top collaborators of Salima Kalla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Salima Kalla. Salima Kalla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Gatineau, Michel, Éric Dansin, François Chomy, et al.. (2004). Soluble epidermal growth factor receptor (EGFR) and HER-2 monitoring in a Phase II combination of gefitinib (ZD1839) and docetaxel for non-small-cell lung cancer (NSCLC). Journal of Clinical Oncology. 22(14_suppl). 7090–7090. 6 indexed citations
2.
Spielmann, M., Antonio Llombart‐Cussac, Salima Kalla, et al.. (2001). Single-Agent Gemcitabine Is Active in Previously Treated Metastatic Breast Cancer. Oncology. 60(4). 303–307. 122 indexed citations
3.
Misset, J. L., Véronique Dièras, G. Gruia, et al.. (1999). Dose-finding study of docetaxel and doxorubicin in first-line treatment of patients with metastatic breast cancer. Annals of Oncology. 10(5). 553–560. 106 indexed citations
4.
Wasserman, Ernesto, C. Cuvier, François Lokiec, et al.. (1999). Combination of Oxaliplatin Plus Irinotecan in Patients With Gastrointestinal Tumors: Results of Two Independent Phase I Studies With Pharmacokinetics. Journal of Clinical Oncology. 17(6). 1751–1751. 111 indexed citations
5.
Dièras, Véronique, et al.. (1997). Docetaxel in combination with doxorubicin or vinorelbine. European Journal of Cancer. 33. S20–S22. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P. Marpicati Breakdown of academic impact, for papers by Hideaki Aoyama Breakdown of academic impact, for papers by R. K. Ramanathan Breakdown of academic impact, for papers by Mario Brandi Breakdown of academic impact, for papers by S. Sugarman Breakdown of academic impact, for papers by Monica Capozzi Breakdown of academic impact, for papers by Sachi Morita Breakdown of academic impact, for papers by Nebojša Manojlović Breakdown of academic impact, for papers by Giovanna Antonelli Breakdown of academic impact, for papers by Johan M. van Rooijen
Rankless by CCL
2026